Sector Alpha Week of 2026-09-11
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-11

Aurionpro Solutions Ltd

AURIONPRO
IT - Software

Aurionpro Solutions Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

The sharpest disagreement: annual EPS moved +12.3% against a −43.2% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (54 weeks in) while the P/E sits at the 64th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −11.8% year on year, and 69% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Topping out
fundamental trajectory, 12 quarters
Price
₹681
−43.2% 1Y
P/E
18.0×
64th pctile
of its own 11-year range
Revenue (Jun 26)
₹358 Cr
+6.2% YoY
Profit (Jun 26)
₹45.0 Cr
−11.8% YoY
Operating margin
17.0%
−3.0 pp YoY
ROCE
16%
FY26
ROIC
12.1%
vs WACC 12.0% → +0.1 pp
Cash conversion
69%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Aurionpro Solutions Ltd trades at ₹681, in a downtrend and 54 weeks into that stage. That is −23.3% against its own 200-day average. It sits at 0% of a 52-week range of ₹681 to ₹1,207. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (7 weeks and counting).

Today the stock is in a downtrend — week 54 of stage 4, confirmed. At ₹681 it trades −23.3% versus its 200-day average and sits at 0% of its 52-week range (₹681–₹1,207).

Sep 26: ₹681 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−23.3% versus the 200-day line, week 54 of stage 4
Price50-day avg200-day avg
S2S4S4₹2,059₹1,601₹1,144₹687₹230₹681₹888Sep 23Jun 24Mar 25Jan 26Sep 26
S2S4S4₹2,059₹1,601₹1,144₹687₹230₹681₹888Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (555 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +1,036% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (7 weeks and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Aurionpro Solutions Ltd trades at 18.0× P/E, mid-range by its own standards (64th percentile). Its long-run median P/E is 11.5×, measured across 10.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 18.0× is mid-range by its own standards (64th percentile), against a long-run median of 11.5× measured over 10.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 18.0× vs a 11.5× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.6-year window; loss-period spikes above 35× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
mid-range by its own standards (64th percentile)
P/EMedianEPS (TTM) (quarterly)
37.1×₹42.627.8×₹31.918.5×₹21.39.3×₹10.60.0×₹0.0×17.90×₹38Feb 16Jul 18Jan 21May 24Sep 26
37.1×₹42.627.8×₹31.918.5×₹21.39.3×₹10.60.0×₹0.0×17.90×₹38Feb 16Jan 21Sep 26
PEG 0.60 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 20 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
1.1×0.8×0.6×0.4×0.2××0.60×Q1 FY22Q1 FY23Q2 FY24Q3 FY25Q4 FY26
1.1×0.8×0.6×0.4×0.2××0.60×Q1 FY22Q2 FY24Q4 FY26
P/E
18.0×
64th percentile of 11y
PEG
0.65
as reported

Why the multiple sits where it does: over the past year annual EPS moved +12.3% against a −43.2% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 10y, of the +28.3%/yr price move, ~+13.6%/yr came from earnings growth and ~+14.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · What the price assumes

What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.

Solved at its 13 June 2026 price, Aurionpro Solutions Ltd was paying for profit growth of about 11.2% a year. Profit itself has compounded 14.4% a year over the past 10 years. Today the market pays 18.0× P/E, the 64th percentile of its own 11-year range.

What the two numbers say together. The multiple is unremarkable against its own past, and the growth the price is paying for is close to what this company has actually delivered.

How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.

04 · Stage: Topping out

Stage: Topping out Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Aurionpro Solutions Ltd reads as topping out on its fundamental arc. Topping out — revenue, profit and EPS growth have decelerated hard (revenue growth +35.4% at its peak → +14.8% latest) while ROCE still reads 15.5%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +20.3% in FY26, profit +12.8% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
40%209%21%72%2.2%−64%−17%−201%−36%−338%%%20.3%12.8%FY16FY21FY26
40%209%21%72%2.2%−64%−17%−201%−36%−338%%%20.3%12.8%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue rolling over, profit rolling over
RevenueProfitEPS
39%46%33%35%26%24%20%13%13%2.0%%%14.8%5.1%5%Sep 23Dec 24Jun 26
39%46%33%35%26%24%20%13%13%2.0%%%14.8%5.1%5%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
28%25%21%18%15%%15.5%Sep 23Mar 24Dec 24Sep 25Jun 26
28%25%21%18%15%%15.5%Sep 23Dec 24Jun 26
Revenue growth
Rolling over
latest +14.8% · span +14.8% to +37.3%
Profit growth
Rolling over
latest +5.1% · span +5.1% to +43.1%
EPS growth
Rolling over
latest +5.0% · span +5.0% to +34.1%
ROCE
Rolling over
latest 15.5% · span 15.5%–27.3%

Why it matters: decelerating from a peak is where good stories quietly end — the multiple usually notices late.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+20.3%+28.9%+30.4%+7.1%
Profit+12.8%+27.6%+14.4%
EPS+12.3%+21.1%+11.9%
Share price−43.2%+5.0%+46.3%+28.3%
Revenue YoY (Jun 26)
+6.2%
latest quarter vs a year ago
Profit YoY (Jun 26)
−11.8%
latest quarter vs a year ago
Revenue 10y
7.1%
long-run compound pace
05 · 4-Factor Sector Score

4-Factor Sector Score

36.1/100 — rank 50 of 64 in IT - Software · 93% evidence confidence

Aurionpro Solutions Ltd scores 36.1 out of 100 against the 64 companies it is compared with in IT - Software, ranking 50. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 12.9 + 10.7 + 10 + 2.5 = 36.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

06 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Aurionpro Solutions Ltd reported ₹358 Cr of revenue in the Jun 26 quarter, +6.2% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 7.1% a year. The last full year, FY26, came in at ₹1,411 Cr. The last four reported quarters add to ₹1,433 Cr.

FY26 revenue came in at ₹1,411 Cr (+20.3% on the year), capping 10 years at 7.1% compound. The latest quarter (Jun 26) printed ₹358 Cr, +6.2% year on year — the 12th consecutive quarter of year-over-year growth.

FY26 revenue ₹1,411 Cr (+20.3% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
7.1% a year over 10 years
RevenueYoY growth
1.5k40%1.1k21%7622.2%381−17%0−36%₹ Cr%₹1,41120.3%FY16FY21FY26
1.5k40%1.1k21%7622.2%381−17%0−36%₹ Cr%₹1,41120.3%FY16FY21FY26
Jun 26: ₹358 Cr (+6.2% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
40140%30131%20022%10012%03.3%₹ Cr%₹3586.2%Sep 23Dec 24Jun 26
40140%30131%20022%10012%03.3%₹ Cr%₹3586.2%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +15.5% growth against the decade's 7.1% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +14.8% over the last 4 quarters against +22.8%/yr over the last 8 — rolling over; TTM profit +5.1% vs +14.9%/yr — rolling over.

07 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Aurionpro Solutions Ltd's operating margin is 17.0% in the Jun 26 quarter, −3.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 9.0% to 23.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 17.0%, −3.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 9.0%–23.0%.

🚨 Why the margin moved: operating margin went −3.1 pp year on year while gross margin went +0.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY26: 20.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 9.0–23.0% band over 13 years
operating marginYoY change (pp)
24%11%20%6.8%16%2.5%12%−1.8%7.9%−6.2%%%20%−1%FY14FY20FY26
24%11%20%6.8%16%2.5%12%−1.8%7.9%−6.2%%%20%−1%FY14FY20FY26
Jun 26: 17.0% operating margin (−3.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
22%0.2%21%−0.6%20%−1.5%18%−2.4%17%−3.2%%%17%−3%Sep 23Dec 24Jun 26
22%0.2%21%−0.6%20%−1.5%18%−2.4%17%−3.2%%%17%−3%Sep 23Dec 24Jun 26
08 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Aurionpro Solutions Ltd earned ₹45.0 Cr of net profit in the Jun 26 quarter, −11.8% year on year. Full-year FY26 profit was ₹212 Cr. The 10-year compound rate is 14.4%. That is 12.6% of the quarter's revenue. The same quarter a year earlier earned ₹51.0 Cr.

Jun 26 profit was ₹45.0 Cr, −11.8% year on year. On the full year, FY26 printed ₹212 Cr (+12.8%), and the 10-year compound rate is 14.4%.

FY26 profit ₹212 Cr (+12.8% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
14.4% a year over 10 years
Net profitYoY growth
244241%127−12%10−264%−107−517%−224−770%₹ Cr%₹21212.8%FY16FY21FY26
244241%127−12%10−264%−107−517%−224−770%₹ Cr%₹21212.8%FY16FY21FY26
Jun 26: ₹45.0 Cr (−11.8% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
6651%4934%3317%160.0%0−16%₹ Cr%₹45−11.8%Sep 23Dec 24Jun 26
6651%4934%3317%160.0%0−16%₹ Cr%₹45−11.8%Sep 23Dec 24Jun 26

🚨 Why profit moved: revenue contributed +6.2% and the margin −3.0 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit +5.3% vs revenue +15.5%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

09 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 69% of Aurionpro Solutions Ltd's reported profit arrived as operating cash — most of the profit is real cash. In FY26 that was ₹56.0 Cr of operating cash against ₹212 Cr of profit. After ₹179 Cr of capital spending, ₹−123 Cr was left as free cash.

FY26: operating cash of ₹56.0 Cr against reported profit of ₹212 Cr, leaving free cash of ₹−123 Cr after ₹179 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 69% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹56.0 Cr vs profit ₹212 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution.
69% of 3-year profit arrived as cash
Operating cashNet profitFree cash
24412710−107−224₹ Cr₹56₹212₹−123FY16FY21FY26
24412710−107−224₹ Cr₹56₹212₹−123FY16FY21FY26
FY26: CFO = 26% of profit (three-year rate 69%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
279%211%143%75%7.3%%26%FY16FY21FY26
279%211%143%75%7.3%%26%FY16FY21FY26

🚨 Why conversion sits at 69%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle. Less than 70% of profit arriving as cash is the thing to watch on this page.

Router verdict: the bigger cash user is investment — capital spending ran 8.5× depreciation over three years, so the next section's job is to check what that build-out is buying.

10 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Aurionpro Solutions Ltd's cash conversion cycle runs 98 days in FY26, down from 101 days in FY21. Capital spending ran ₹763 Cr over the last 3 years. At FY26 sales of ₹1,411 Cr each day of that cycle holds about ₹3.9 Cr, so roughly ₹379 Cr sits inside the business at any moment.

FY26: debtors at 98 days (an asset-light business — no inventory to speak of) — for a full cycle of 98 days, tighter than FY21's 101.

In money terms: at FY26 sales of ₹1,411 Cr, each day of the cycle holds about ₹3.9 Cr — so the 98-day loop keeps roughly ₹379 Cr sitting inside the business at any moment.

FY26: a 98-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
−3 days vs FY21
Cash cycleDebtor days
13612411210088days98d98dFY14FY17FY20FY23FY26
13612411210088days98d98dFY14FY20FY26

On the investment side: capital spending of ₹763 Cr over the last 3 fiscal years against ₹90.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹179 Cr, work-in-progress ₹0.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
34721277−58−193₹ Cr₹179₹0FY16FY18FY21FY23FY26
34721277−58−193₹ Cr₹179₹0FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

11 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Aurionpro Solutions Ltd earns a ROCE of 16% in FY26. That is up from a trough of −8% in FY21. Return on invested capital clears the cost of that capital by +0.1 percentage points, so growth here adds value rather than only size. The wiring behind it is 15.0% net margin on 0.60× asset turns.

FY26 ROCE is 16%, recovered from a FY21 trough of −8% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 15.0% net margin × 0.60× asset turns × 1.34× balance-sheet leverage ≈ 12.1% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 12.1% − 12.0% = a +0.1 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.

FY26: ROCE 16% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY21's −8%
ROCEROIC (annual)WACC
28%18%8.5%−1.1%−11%%16%15.7%FY14FY20FY26
28%18%8.5%−1.1%−11%%16%15.7%FY14FY20FY26
Q4 FY26: ROCE 13.3% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 11 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
24%21%18%14%11%%13.3%16.1%Q2 FY24Q3 FY25Q4 FY26
24%21%18%14%11%%13.3%16.1%Q2 FY24Q3 FY25Q4 FY26
12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Aurionpro Solutions Ltd carries total debt of ₹61.0 Cr against shareholder equity of ₹1,745 Cr as of Mar 26, a debt-to-equity of 0.03 — effectively unlevered. On the annual view that ratio went from 0.15 in FY22 to 0.03 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹61.0 Cr against shareholder equity of ₹1,745 Cr — a debt-to-equity of 0.03. On the annual view, debt-to-equity went from 0.15 (FY22) to 0.03 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹61.0 Cr at 0.03× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
950.18×710.14×480.10×240.05×00.01×₹ Cr×₹610.03×FY22FY24FY26
950.18×710.14×480.10×240.05×00.01×₹ Cr×₹610.03×FY22FY24FY26
Mar 26: debt ₹61.0 Cr, debt-to-equity 0.03 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
1300.18×970.14×650.10×320.05×00.01×₹ Cr×₹610.03×Jun 23Sep 24Mar 26
1300.18×970.14×650.10×320.05×00.01×₹ Cr×₹610.03×Jun 23Sep 24Mar 26
13 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions added 3.2 points of Aurionpro Solutions Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 16.0% of the company. Domestic institutions moved −0.2 points over the same window, to 1.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: +3.2 points over 8 quarters to 16.0%; Domestic institutions: −0.2 points over 8 quarters to 1.5%; Promoters: +0.0 points over 8 quarters to 26.9%.

Why the register moved: foreign institutions drove it (+3.2 points) — steady accumulation by institutions reading the same numbers this page reads.

Fiscal-year ends: promoters −3.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
68%50%32%14%−4.3%%26.9%16.3%1.3%55.6%Mar 24Mar 25Mar 26
68%50%32%14%−4.3%%26.9%16.3%1.3%55.6%Mar 24Mar 25Mar 26
Foreign institutions added 3.2 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
71%52%33%14%−5.0%%26.9%16.0%1.5%55.6%Jun 23Dec 24Jun 26
71%52%33%14%−5.0%%26.9%16.0%1.5%55.6%Jun 23Dec 24Jun 26
14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Aurionpro Solutions Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

15 · Related companies · IT - Software
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Coforge LtdCOFORGE 76.3/100Favorable setup100% evidence LEADER 30.0/35 Revenue 35.7% · PAT 66.5% · OPM change 3 pp 100% evidence 15.6/25 ROCE 23.5% · OPM 19% 100% evidence 12.3/20 P/E 42.7× · PEG 0.57 100% evidence 18.4/20 RS sector 13.3% · RS bench 20.1% · 1Y 11.3%12 of 12 weeks ahead 100% evidence
Exact sum: 30 + 15.6 + 12.3 + 18.4 = 76.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Silver Touch Technologies LtdSILVERTUC 70.0/100Favorable setup93% evidence FADING 30.2/35 Revenue 21.1% · PAT 86.4% · OPM change 8 pp 100% evidence 17.4/25 ROCE 29.8% · OPM 22% 100% evidence 10.3/20 P/E 46.4× · PEG 1.11 65% evidence 12.1/20 RS sector 6.1% · RS bench 14.1% · 1Y 120.3%9 of 12 weeks ahead 100% evidence
Exact sum: 30.2 + 17.4 + 10.3 + 12.1 = 70 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3Sahana Systems LtdSAHANA 68.7/100Favorable setup70% evidence TURNING 21.5/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence 19.9/25 ROCE 39.8% · OPM 29% 95% evidence 13.4/20 P/E 14.1× · PEG — 50% evidence 13.9/20 RS sector -5.2% · RS bench 15.9% · 1Y -24.3%3 of 12 weeks ahead 100% evidence
Exact sum: 21.5 + 19.9 + 13.4 + 13.9 = 68.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4ASM Technologies Ltd526433 68.2/100Favorable setup69% evidence BREAKING OUT 27.9/35 Revenue 67.8% · PAT 89.5% · OPM change 2 pp 95% evidence 16.1/25 ROCE 27% · OPM 23% 76% evidence 8.6/20 P/E 138× · PEG — 15% evidence 15.6/20 RS sector 5.7% · RS bench 97.1% · 1Y 94%10 of 10 weeks ahead 70% evidence
Exact sum: 27.9 + 16.1 + 8.6 + 15.6 = 68.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5NINtec Systems LtdNINSYS 65.0/100Favorable setup80% evidence FADING 20.0/35 Revenue 21.6% · PAT 18.8% · OPM change 4.2 pp 95% evidence 21.9/25 ROCE 54% · OPM 25.9% 95% evidence 9.3/20 P/E 39.3× · PEG — 15% evidence 13.8/20 RS sector 29.6% · RS bench 37.6% · 1Y 57.1%9 of 12 weeks ahead 100% evidence
Exact sum: 20 + 21.9 + 9.3 + 13.8 = 65 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6String Metaverse Ltd534535 63.4/100Mixed-positive evidence82% evidence BASING 27.2/35 Revenue 100% · PAT 100% · OPM change 0 pp 95% evidence 15.7/25 ROCE 41.6% · OPM 11% 76% evidence 14.8/20 P/E 8.2× · PEG — 50% evidence 5.7/20 RS sector -48% · RS bench -35.6% · 1Y -70.4%1 of 12 weeks ahead 100% evidence
Exact sum: 27.2 + 15.7 + 14.8 + 5.7 = 63.4 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -48% and the one-year return is -70.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
7Cigniti Technologies LtdCIGNITITEC 63.3/100Mixed-positive evidence73% evidence 23.4/35 Revenue 14% · PAT 96.1% · OPM change 2 pp 56% evidence 16.2/25 ROCE 34.1% · OPM 18% 75% evidence 16.2/20 P/E 11.4× · PEG 0.61 100% evidence 7.5/20 RS sector -10.2% · RS bench -15% · 1Y -19.7%0 of 12 weeks ahead to 2026-05-17 70% evidence
Exact sum: 23.4 + 16.2 + 16.2 + 7.5 = 63.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Tech Mahindra LtdTECHM 63.2/100Mixed-positive evidence94% evidence BREAKING OUT 21.1/35 Revenue 10.9% · PAT 14.3% · OPM change 3 pp 100% evidence 16.3/25 ROCE 23.1% · OPM 17% 100% evidence 10.6/20 P/E 28.4× · PEG 0.76 100% evidence 15.2/20 RS sector 14.8% · RS bench 4% · 1Y 4.3%8 of 11 weeks ahead 70% evidence
Exact sum: 21.1 + 16.3 + 10.6 + 15.2 = 63.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9TAC Infosec LtdTAC 63.0/100Mixed-positive evidence66% evidence TURNING 25.6/35 Revenue 76.4% · PAT 59.4% · OPM change 1.6 pp 71% evidence 20.9/25 ROCE 38.1% · OPM 48.2% 95% evidence 9.5/20 P/E 35.7× · PEG — 15% evidence 7.0/20 RS sector -13.2% · RS bench -15.4% · 1Y -14.4%4 of 10 weeks ahead 70% evidence
Exact sum: 25.6 + 20.9 + 9.5 + 7 = 63 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Sasken Technologies LtdSASKEN 61.6/100Mixed-positive evidence100% evidence FADING 30.7/35 Revenue 67.8% · PAT 67.4% · OPM change 4 pp 100% evidence 8.1/25 ROCE 9.9% · OPM 9% 100% evidence 10.4/20 P/E 36.7× · PEG 0.68 100% evidence 12.4/20 RS sector 9.5% · RS bench 16.6% · 1Y 25%8 of 12 weeks ahead 100% evidence
Exact sum: 30.7 + 8.1 + 10.4 + 12.4 = 61.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Softtech Engineers LtdSOFTTECH 60.8/100Mixed-positive evidence80% evidence TURNING 25.2/35 Revenue 35.8% · PAT 100% · OPM change -0.1 pp 95% evidence 12.1/25 ROCE 6.2% · OPM 27.2% 95% evidence 8.7/20 P/E 124× · PEG — 15% evidence 14.8/20 RS sector 19.9% · RS bench 27.6% · 1Y 13.7%6 of 12 weeks ahead 100% evidence
Exact sum: 25.2 + 12.1 + 8.7 + 14.8 = 60.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Datamatics Global Services LtdDATAMATICS 60.7/100Mixed-positive evidence94% evidence ASLEEP 21.0/35 Revenue 13.1% · PAT 1.9% · OPM change 4 pp 100% evidence 15.9/25 ROCE 20.4% · OPM 20% 100% evidence 10.6/20 P/E 17.7× · PEG 0.69 100% evidence 13.2/20 RS sector 9.6% · RS bench -3.3% · 1Y -21.3%5 of 10 weeks ahead 70% evidence
Exact sum: 21 + 15.9 + 10.6 + 13.2 = 60.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13IZMO LtdIZMO 60.6/100Mixed-positive evidence81% evidence FADING 24.1/35 Revenue 24.7% · PAT 10.2% · OPM change 8 pp 95% evidence 14.2/25 ROCE 12.6% · OPM 25% 95% evidence 6.6/20 P/E 25.3× · PEG — 50% evidence 15.7/20 RS sector 29% · RS bench 7.6% · 1Y 20.9%8 of 10 weeks ahead 70% evidence
Exact sum: 24.1 + 14.2 + 6.6 + 15.7 = 60.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Danlaw Technologies India Ltd532329 59.9/100Mixed-positive evidence67% evidence TURNING 21.8/35 Revenue 24.1% · PAT 34.5% · OPM change 0.8 pp 95% evidence 15.5/25 ROCE 27.6% · OPM 13.4% 76% evidence 10.2/20 P/E 32× · PEG — 50% evidence 12.4/20 RS sector — · RS bench 93% · 1Y —4 of 4 weeks ahead 25% evidence
Exact sum: 21.8 + 15.5 + 10.2 + 12.4 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Expleo Solutions LtdEXPLEOSOL 59.6/100Mixed-positive evidence81% evidence TURNING 20.9/35 Revenue 10.4% · PAT 39.4% · OPM change 4 pp 95% evidence 15.8/25 ROCE 24.2% · OPM 15% 95% evidence 13.7/20 P/E 9.4× · PEG — 50% evidence 9.2/20 RS sector -13.3% · RS bench 1.4% · 1Y -12.8%2 of 10 weeks ahead 70% evidence
Exact sum: 20.9 + 15.8 + 13.7 + 9.2 = 59.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Hypersoft Technologies Ltd539724 59.6/100Mixed-positive evidence67% evidence FADING 25.5/35 Revenue 100% · PAT 100% · OPM change 2.9 pp 71% evidence 11.9/25 ROCE 20.6% · OPM 14% 76% evidence 8.6/20 P/E 386× · PEG — 15% evidence 13.6/20 RS sector 40.8% · RS bench 50.5% · 1Y 116.6%10 of 12 weeks ahead 100% evidence
Exact sum: 25.5 + 11.9 + 8.6 + 13.6 = 59.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17InfoBeans Technologies LtdINFOBEAN 58.9/100Mixed-positive evidence87% evidence ASLEEP 26.5/35 Revenue 35.5% · PAT 60.4% · OPM change 0 pp 95% evidence 16.9/25 ROCE 29.2% · OPM 21% 95% evidence 9.7/20 P/E 17.6× · PEG — 50% evidence 5.8/20 RS sector -12.9% · RS bench -6.5% · 1Y 10.4%3 of 12 weeks ahead 100% evidence
Exact sum: 26.5 + 16.9 + 9.7 + 5.8 = 58.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -12.9% and the one-year return is 10.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
18R Systems International LtdRSYSTEMS 57.5/100Mixed-positive evidence100% evidence BASING 18.9/35 Revenue 24.1% · PAT -1% · OPM change 3 pp 100% evidence 16.5/25 ROCE 19.5% · OPM 18% 100% evidence 17.7/20 P/E 13.5× · PEG 0.26 100% evidence 4.4/20 RS sector -28.2% · RS bench -23.7% · 1Y -46.9%0 of 12 weeks ahead 100% evidence
Exact sum: 18.9 + 16.5 + 17.7 + 4.4 = 57.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Ksolves India LtdKSOLVES 57.3/100Mixed-positive evidence87% evidence ASLEEP 17.8/35 Revenue 16% · PAT 16.7% · OPM change 3.9 pp 95% evidence 20.7/25 ROCE 131% · OPM 30.3% 95% evidence 13.8/20 P/E 16.5× · PEG — 50% evidence 5.0/20 RS sector -16.6% · RS bench -10.9% · 1Y -19.3%0 of 12 weeks ahead 100% evidence
Exact sum: 17.8 + 20.7 + 13.8 + 5 = 57.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20BLS E-Services LtdBLSE 56.8/100Mixed-positive evidence75% evidence LEADER 18.1/35 Revenue 71.2% · PAT 9.4% · OPM change 0 pp 95% evidence 10.3/25 ROCE 16.4% · OPM 7% 76% evidence 9.0/20 P/E 48.9× · PEG — 15% evidence 19.4/20 RS sector 41.8% · RS bench 50.4% · 1Y 75.9%12 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 10.3 + 9 + 19.4 = 56.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Subex LtdSUBEXLTD 56.5/100Mixed-positive evidence65% evidence BREAKING OUT 24.4/35 Revenue 2.8% · PAT 100% · OPM change 13 pp 95% evidence 10.3/25 ROCE 12.8% · OPM 19% 95% evidence 9.4/20 P/E 36.2× · PEG — 15% evidence 12.4/20 RS sector — · RS bench 80.4% · 1Y —9 of 9 weeks ahead 25% evidence
Exact sum: 24.4 + 10.3 + 9.4 + 12.4 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Saksoft LtdSAKSOFT 55.7/100Mixed-positive evidence100% evidence BREAKING OUT 17.9/35 Revenue 8.2% · PAT 13% · OPM change 0 pp 100% evidence 15.6/25 ROCE 25.5% · OPM 18% 100% evidence 13.5/20 P/E 14.5× · PEG 0.6 100% evidence 8.7/20 RS sector -16% · RS bench -10.8% · 1Y -30.5%12 of 12 weeks ahead 100% evidence
Exact sum: 17.9 + 15.6 + 13.5 + 8.7 = 55.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Infosys LtdINFY 55.1/100Mixed-positive evidence82% evidence ASLEEP 18.1/35 Revenue 11.2% · PAT 11.1% · OPM change 0 pp 95% evidence 20.1/25 ROCE 40% · OPM 24% 76% evidence 14.0/20 P/E 13.5× · PEG — 50% evidence 2.9/20 RS sector -26.2% · RS bench -21.2% · 1Y -28.2%0 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 20.1 + 14 + 2.9 = 55.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24LTM LtdLTM 54.4/100Mixed-positive evidence100% evidence BREAKING OUT 17.1/35 Revenue 13.9% · PAT 10% · OPM change 1 pp 100% evidence 17.9/25 ROCE 29.6% · OPM 18% 100% evidence 10.7/20 P/E 22.6× · PEG 1.18 100% evidence 8.7/20 RS sector -17.1% · RS bench -11.7% · 1Y -17.7%5 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 17.9 + 10.7 + 8.7 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25AvenuesAI LtdCCAVENUE 53.6/100Mixed-positive evidence93% evidence BREAKING OUT 20.9/35 Revenue 100% · PAT 43.8% · OPM change -2.3 pp 100% evidence 5.0/25 ROCE 7.7% · OPM 3.7% 100% evidence 14.8/20 P/E 19.2× · PEG 0.37 65% evidence 12.9/20 RS sector -4.7% · RS bench 1.7% · 1Y 0.7%12 of 12 weeks ahead 100% evidence
Exact sum: 20.9 + 5 + 14.8 + 12.9 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Xchanging Solutions LtdXCHANGING 53.6/100Mixed-positive evidence81% evidence TURNING 18.6/35 Revenue 8.4% · PAT 13.2% · OPM change 1 pp 95% evidence 15.5/25 ROCE 18% · OPM 34% 95% evidence 13.6/20 P/E 11.4× · PEG — 50% evidence 5.9/20 RS sector -24.4% · RS bench -11.2% · 1Y -30.2%1 of 10 weeks ahead 70% evidence
Exact sum: 18.6 + 15.5 + 13.6 + 5.9 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Blue Cloud Softech Solutions LtdBLUECLOUDS 53.0/100Mixed-positive evidence74% evidence 22.0/35 Revenue 41.1% · PAT 36.2% · OPM change 10 pp 95% evidence 12.4/25 ROCE 14.2% · OPM 20% 95% evidence 9.6/20 P/E 27.6× · PEG — 15% evidence 9.0/20 RS sector -3.8% · RS bench -8.7% · 1Y -33.2%1 of 12 weeks ahead 70% evidence
Exact sum: 22 + 12.4 + 9.6 + 9 = 53 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28TechNVision Ventures LtdTECHNVISN 52.9/100Mixed-positive evidence74% evidence ASLEEP 25.9/35 Revenue 23.4% · PAT 100% · OPM change 2.9 pp 95% evidence 5.5/25 ROCE 12.9% · OPM 5.2% 95% evidence 8.5/20 P/E 1002× · PEG — 15% evidence 13.0/20 RS sector 32.1% · RS bench -14% · 1Y -20.6%0 of 9 weeks ahead 70% evidence
Exact sum: 25.9 + 5.5 + 8.5 + 13 = 52.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
29Seshaasai Technologies LtdSTYL 52.3/100Mixed-positive evidence73% evidence BREAKING OUT 12.6/35 Revenue 6.7% · PAT 20.6% · OPM change 0 pp 100% evidence 17.1/25 ROCE 27.7% · OPM 23% 100% evidence 12.6/20 P/E 23.7× · PEG 0.81 65% evidence 10.0/20 RS sector — · RS bench — · 1Y -9.1%10 of 10 weeks ahead 0% evidence
Exact sum: 12.6 + 17.1 + 12.6 + 10 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
30Tanla Platforms LtdTANLA 52.2/100Mixed-positive evidence94% evidence ASLEEP 14.4/35 Revenue 13.2% · PAT 9.9% · OPM change 0 pp 100% evidence 16.5/25 ROCE 26.3% · OPM 16% 100% evidence 13.1/20 P/E 12.5× · PEG 1.21 100% evidence 8.2/20 RS sector -12% · RS bench -5.7% · 1Y -23.7%6 of 10 weeks ahead 70% evidence
Exact sum: 14.4 + 16.5 + 13.1 + 8.2 = 52.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
31Tata Consultancy Services LtdTCS 50.6/100Mixed-positive evidence100% evidence TURNING 10.0/35 Revenue 7.7% · PAT 1.1% · OPM change -1 pp 100% evidence 22.5/25 ROCE 63% · OPM 26% 100% evidence 11.9/20 P/E 14.8× · PEG 1.85 100% evidence 6.2/20 RS sector -21.5% · RS bench -16.2% · 1Y -27.8%0 of 12 weeks ahead 100% evidence
Exact sum: 10 + 22.5 + 11.9 + 6.2 = 50.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
32Capillary Technologies India LtdCAPILLARY 50.4/100Mixed-positive evidence63% evidence ASLEEP 27.4/35 Revenue 27.8% · PAT 135.8% · OPM change 5.8 pp 100% evidence 4.1/25 ROCE 3.4% · OPM 15.7% 100% evidence 8.9/20 P/E 71.8× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence
Exact sum: 27.4 + 4.1 + 8.9 + 10 = 50.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
33RNIT AI Solutions LtdAUTOPALIND 50.4/100Thin evidence · provisional55% evidence BREAKING OUT 16.9/35 Revenue 56.7% · PAT 71.3% · OPM change -0.6 pp 95% evidence 14.6/25 ROCE 20.2% · OPM 35.3% 76% evidence 8.9/20 P/E 68× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —5 of 12 weeks ahead 0% evidence
Exact sum: 16.9 + 14.6 + 8.9 + 10 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
34Birlasoft LtdBSOFT 50.3/100Mixed-positive evidence100% evidence ASLEEP 19.7/35 Revenue 1.4% · PAT 21.1% · OPM change 4 pp 100% evidence 13.0/25 ROCE 21.2% · OPM 16% 100% evidence 14.6/20 P/E 13.2× · PEG 0.62 100% evidence 3.0/20 RS sector -26% · RS bench -20.6% · 1Y -25%0 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 13 + 14.6 + 3 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
35Mphasis LtdMPHASIS 49.0/100Mixed-negative evidence94% evidence FADING 15.0/35 Revenue 13.7% · PAT 9.9% · OPM change -1 pp 100% evidence 17.3/25 ROCE 22.1% · OPM 18% 100% evidence 6.0/20 P/E 22.6× · PEG 2.19 100% evidence 10.7/20 RS sector 0% · RS bench -7% · 1Y -18%3 of 10 weeks ahead 70% evidence
Exact sum: 15 + 17.3 + 6 + 10.7 = 49 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
36Hexaware Technologies LtdHEXT 48.9/100Mixed-negative evidence94% evidence FADING 14.2/35 Revenue 13% · PAT 1.2% · OPM change 4 pp 100% evidence 17.8/25 ROCE 30.1% · OPM 16% 100% evidence 10.7/20 P/E 21.4× · PEG 0.81 100% evidence 6.2/20 RS sector -21.4% · RS bench -14.7% · 1Y -31.1%6 of 10 weeks ahead 70% evidence
Exact sum: 14.2 + 17.8 + 10.7 + 6.2 = 48.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
37HCL Technologies LtdHCLTECH 48.2/100Mixed-negative evidence82% evidence BREAKING OUT 12.2/35 Revenue 12.6% · PAT 2.6% · OPM change 0 pp 95% evidence 19.0/25 ROCE 30.4% · OPM 20% 76% evidence 9.0/20 P/E 18× · PEG — 50% evidence 8.0/20 RS sector -18.3% · RS bench -12.7% · 1Y -15%7 of 12 weeks ahead 100% evidence
Exact sum: 12.2 + 19 + 9 + 8 = 48.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
38Mastek LtdMASTEK 47.9/100Mixed-negative evidence82% evidence FADING 13.8/35 Revenue 6% · PAT 5% · OPM change 0 pp 95% evidence 13.3/25 ROCE 17.7% · OPM 15% 76% evidence 12.6/20 P/E 11.5× · PEG — 50% evidence 8.2/20 RS sector -16.4% · RS bench -11.1% · 1Y -33.2%4 of 12 weeks ahead 100% evidence
Exact sum: 13.8 + 13.3 + 12.6 + 8.2 = 47.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
39Dynacons Systems & Solutions LtdDSSL 47.2/100Mixed-negative evidence87% evidence ASLEEP 16.8/35 Revenue 10.5% · PAT 16.2% · OPM change 3 pp 95% evidence 15.4/25 ROCE 29.8% · OPM 13% 95% evidence 8.1/20 P/E 15.9× · PEG — 50% evidence 6.9/20 RS sector -7% · RS bench -0.5% · 1Y 9%6 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 15.4 + 8.1 + 6.9 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
40Zensar Technologies LtdZENSARTECH 46.6/100Mixed-negative evidence100% evidence ASLEEP 15.6/35 Revenue 8% · PAT 15.3% · OPM change 0 pp 100% evidence 13.6/25 ROCE 22.8% · OPM 15% 100% evidence 14.3/20 P/E 12.2× · PEG 1.11 100% evidence 3.1/20 RS sector -33% · RS bench -28.6% · 1Y -45.2%0 of 12 weeks ahead 100% evidence
Exact sum: 15.6 + 13.6 + 14.3 + 3.1 = 46.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
41Unicommerce eSolutions LtdUNIECOM 46.6/100Mixed-negative evidence74% evidence ASLEEP 14.4/35 Revenue 38.4% · PAT 18.1% · OPM change -8.1 pp 95% evidence 16.5/25 ROCE 21.1% · OPM 10.6% 95% evidence 9.1/20 P/E 44.1× · PEG — 15% evidence 6.6/20 RS sector -14.5% · RS bench -19.2% · 1Y -44.1%0 of 10 weeks ahead 70% evidence
Exact sum: 14.4 + 16.5 + 9.1 + 6.6 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
42XT Global Infotech LtdXTGLOBAL 46.5/100Mixed-negative evidence61% evidence 18.4/35 Revenue 85.4% · PAT 29.4% · OPM change -6.6 pp 53% evidence 9.4/25 ROCE 7.5% · OPM 9.5% 71% evidence 9.1/20 P/E 40.8× · PEG — 50% evidence 9.6/20 RS sector -1% · RS bench -12.7% · 1Y -21.9%2 of 12 weeks ahead to 2026-03-29 70% evidence
Exact sum: 18.4 + 9.4 + 9.1 + 9.6 = 46.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
43Wipro LtdWIPRO 45.0/100Mixed-negative evidence100% evidence BASING 12.9/35 Revenue 6.4% · PAT -1.7% · OPM change 0 pp 100% evidence 15.3/25 ROCE 17.8% · OPM 19% 100% evidence 13.5/20 P/E 12.5× · PEG 1.4 100% evidence 3.3/20 RS sector -25.8% · RS bench -20.8% · 1Y -31.3%0 of 12 weeks ahead 100% evidence
Exact sum: 12.9 + 15.3 + 13.5 + 3.3 = 45 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
44Excelsoft Technologies LtdEXCELSOFT 44.3/100Mixed-negative evidence60% evidence TURNING 12.0/35 Revenue 26.8% · PAT 4.2% · OPM change -1.8 pp 95% evidence 12.2/25 ROCE 13.6% · OPM 16.3% 95% evidence 10.1/20 P/E 18.7× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence
Exact sum: 12 + 12.2 + 10.1 + 10 = 44.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
45Sonata Software LtdSONATSOFTW 43.1/100Mixed-negative evidence100% evidence BREAKING OUT 9.0/35 Revenue 4% · PAT 7.9% · OPM change 0 pp 100% evidence 13.6/25 ROCE 30.7% · OPM 5% 100% evidence 13.1/20 P/E 14.7× · PEG 0.81 100% evidence 7.4/20 RS sector -17.3% · RS bench -12.1% · 1Y -25.9%11 of 12 weeks ahead 100% evidence
Exact sum: 9 + 13.6 + 13.1 + 7.4 = 43.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
4663 Moons Technologies Ltd63MOONS 43.1/100Thin evidence · provisional58% evidence BREAKING OUT 20.6/35 Revenue 100% · PAT -80% · OPM change 128 pp 71% evidence 3.4/25 ROCE -3.7% · OPM -52% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 9.1/20 RS sector -22.4% · RS bench 28.9% · 1Y -1.6%10 of 11 weeks ahead 70% evidence
Exact sum: 20.6 + 3.4 + 10 + 9.1 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
47Magellanic Cloud LtdMCLOUD 38.9/100Mixed-negative evidence81% evidence TURNING 9.6/35 Revenue 13.7% · PAT 6.7% · OPM change -7 pp 95% evidence 13.9/25 ROCE 19.8% · OPM 28% 95% evidence 11.9/20 P/E 13.6× · PEG — 50% evidence 3.5/20 RS sector -54.4% · RS bench -23.4% · 1Y -68%6 of 11 weeks ahead 70% evidence
Exact sum: 9.6 + 13.9 + 11.9 + 3.5 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
48Innovana Thinklabs LtdINNOVANA 38.7/100Mixed-negative evidence81% evidence TURNING 8.7/35 Revenue 26% · PAT -39% · OPM change -32.5 pp 95% evidence 11.3/25 ROCE 15.8% · OPM 17.6% 95% evidence 9.0/20 P/E 21.9× · PEG — 50% evidence 9.7/20 RS sector -0.4% · RS bench -15.1% · 1Y -40.3%0 of 10 weeks ahead 70% evidence
Exact sum: 8.7 + 11.3 + 9 + 9.7 = 38.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
49Kellton Tech Solutions LtdKELLTONTEC 36.2/100Mixed-negative evidence87% evidence BASING 10.0/35 Revenue 9.5% · PAT 9.6% · OPM change -1 pp 95% evidence 9.7/25 ROCE 15% · OPM 11% 95% evidence 11.9/20 P/E 8× · PEG — 50% evidence 4.6/20 RS sector -24.3% · RS bench -19.4% · 1Y -45.5%0 of 12 weeks ahead 100% evidence
Exact sum: 10 + 9.7 + 11.9 + 4.6 = 36.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
50Aurionpro Solutions Ltdthis pageAURIONPRO 36.1/100Mixed-negative evidence93% evidence ASLEEP 12.9/35 Revenue 14.8% · PAT 5.1% · OPM change -3 pp 100% evidence 10.7/25 ROCE 16.3% · OPM 17% 100% evidence 10.0/20 P/E 18× · PEG 1.39 65% evidence 2.5/20 RS sector -30.2% · RS bench -25.6% · 1Y -47.2%2 of 12 weeks ahead 100% evidence
Exact sum: 12.9 + 10.7 + 10 + 2.5 = 36.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
51Allied Digital Services LtdADSL 35.5/100Mixed-negative evidence74% evidence BASING 14.2/35 Revenue 19.1% · PAT 5.6% · OPM change 0 pp 95% evidence 6.5/25 ROCE 7.4% · OPM 9% 95% evidence 10.7/20 P/E 14.6× · PEG — 15% evidence 4.1/20 RS sector -29.8% · RS bench -24.4% · 1Y -39.4%1 of 10 weeks ahead 70% evidence
Exact sum: 14.2 + 6.5 + 10.7 + 4.1 = 35.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
52Mindteck (India) LtdMINDTECK 32.3/100Adverse evidence87% evidence ASLEEP 7.9/35 Revenue -1.8% · PAT 0.3% · OPM change -1.7 pp 95% evidence 10.4/25 ROCE 15.1% · OPM 7.8% 95% evidence 11.8/20 P/E 15.3× · PEG — 50% evidence 2.2/20 RS sector -27.9% · RS bench -23.1% · 1Y -24.6%3 of 12 weeks ahead 100% evidence
Exact sum: 7.9 + 10.4 + 11.8 + 2.2 = 32.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
53Moschip Technologies LtdMOSCHIP 31.1/100Adverse evidence87% evidence TURNING 7.7/35 Revenue 8.4% · PAT -33.6% · OPM change -3.9 pp 100% evidence 7.0/25 ROCE 11% · OPM 8.2% 100% evidence 3.7/20 P/E 129× · PEG 5.04 65% evidence 12.7/20 RS sector 1.9% · RS bench 0.9% · 1Y -15.1%3 of 10 weeks ahead 70% evidence
Exact sum: 7.7 + 7 + 3.7 + 12.7 = 31.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
54Orient Technologies LtdORIENTTECH 30.7/100Thin evidence · provisional54% evidence BASING 15.1/35 Revenue — · PAT — · OPM change -0.5 pp 19% evidence 2.4/25 ROCE 8.4% · OPM 6.7% 95% evidence 9.0/20 P/E 45.6× · PEG — 15% evidence 4.2/20 RS sector -21.8% · RS bench -16.7% · 1Y -9.4%0 of 12 weeks ahead 100% evidence
Exact sum: 15.1 + 2.4 + 9 + 4.2 = 30.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
55Quick Heal Technologies LtdQUICKHEAL 20.4/100Adverse evidence69% evidence BASING 6.2/35 Revenue -6.6% · PAT -80% · OPM change -22.1 pp 71% evidence 1.8/25 ROCE -6% · OPM -39% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 2.4/20 RS sector -32.9% · RS bench -29.1% · 1Y -50.2%2 of 12 weeks ahead 100% evidence
Exact sum: 6.2 + 1.8 + 10 + 2.4 = 20.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
56Covance Softsol Ltd544361 66.8/100Thin evidence · provisional49% evidence 25.8/35 Revenue 43.5% · PAT 100% · OPM change 19.7 pp 62% evidence 17.8/25 ROCE 31.4% · OPM 23.1% 76% evidence 11.1/20 P/E 12.9× · PEG — 15% evidence 12.1/20 RS sector — · RS bench 48.4% · 1Y — 25% evidence
Exact sum: 25.8 + 17.8 + 11.1 + 12.1 = 66.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
57Exato Technologies Ltd544626 57.8/100Thin evidence · provisional38% evidence TURNING 21.0/35 Revenue — · PAT — · OPM change 3.4 pp 45% evidence 17.5/25 ROCE 26.8% · OPM 18% 76% evidence 9.3/20 P/E 40× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —4 of 4 weeks ahead 0% evidence
Exact sum: 21 + 17.5 + 9.3 + 10 = 57.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
58Unified Data- Tech Solutions LtdUNIFIED 56.1/100Thin evidence · provisional36% evidence 16.9/35 Revenue — · PAT — · OPM change 1 pp 26% evidence 18.8/25 ROCE 45.2% · OPM 15% 76% evidence 10.2/20 P/E 18.6× · PEG — 15% evidence 10.2/20 RS sector — · RS bench -1.2% · 1Y 15.3%0 of 12 weeks ahead 25% evidence
Exact sum: 16.9 + 18.8 + 10.2 + 10.2 = 56.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
59Kody Technolab LtdKODYTECH 54.2/100Thin evidence · provisional48% evidence BREAKING OUT 15.2/35 Revenue — · PAT — · OPM change -5 pp 19% evidence 14.4/25 ROCE 16.8% · OPM 29% 95% evidence 8.7/20 P/E 125× · PEG — 15% evidence 15.9/20 RS sector 10.3% · RS bench 61.9% · 1Y 107.4%10 of 10 weeks ahead 70% evidence
Exact sum: 15.2 + 14.4 + 8.7 + 15.9 = 54.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
60Metalic Technoforge LtdMETA 53.0/100Thin evidence · provisional27% evidence 16.2/35 Revenue — · PAT — · OPM change -2 pp 13% evidence 17.1/25 ROCE 36.1% · OPM 8% 76% evidence 9.7/20 P/E 25.3× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y -12.7%0 of 12 weeks ahead 0% evidence
Exact sum: 16.2 + 17.1 + 9.7 + 10 = 53 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
61Veefin Solutions LtdVEEFIN 47.3/100Thin evidence · provisional50% evidence 17.7/35 Revenue — · PAT — · OPM change -5.1 pp 19% evidence 10.6/25 ROCE 9.8% · OPM 19.7% 76% evidence 12.2/20 P/E 27.7× · PEG — 50% evidence 6.8/20 RS sector -7.2% · RS bench -24.9% · 1Y -40%0 of 12 weeks ahead 70% evidence
Exact sum: 17.7 + 10.6 + 12.2 + 6.8 = 47.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
62Trident Techlabs LtdTECHLABS 45.8/100Thin evidence · provisional40% evidence 16.0/35 Revenue — · PAT — · OPM change -2 pp 15% evidence 16.2/25 ROCE 26.7% · OPM 27% 71% evidence 10.5/20 P/E 14.9× · PEG — 15% evidence 3.1/20 RS sector -50.2% · RS bench -56.5% · 1Y -72.5%0 of 12 weeks ahead to 2026-03-29 70% evidence
Exact sum: 16 + 16.2 + 10.5 + 3.1 = 45.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
63ERP Soft Systems Ltd530909 44.2/100Thin evidence · provisional41% evidence 19.8/35 Revenue 19.1% · PAT 100% · OPM change -1.1 pp 53% evidence 8.0/25 ROCE 1.6% · OPM 1.7% 57% evidence 8.8/20 P/E 74.9× · PEG — 15% evidence 7.6/20 RS sector — · RS bench -47.6% · 1Y -59.7%0 of 12 weeks ahead to 2026-03-29 25% evidence
Exact sum: 19.8 + 8 + 8.8 + 7.6 = 44.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
64IDream Film Infrastructure Company Ltd504375 38.2/100Thin evidence · provisional35% evidence TURNING 12.8/35 Revenue — · PAT 100% · OPM change — 33% evidence 3.1/25 ROCE -9.2% · OPM -25.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 12.3/20 RS sector — · RS bench 78% · 1Y —8 of 8 weeks ahead 25% evidence
Exact sum: 12.8 + 3.1 + 10 + 12.3 = 38.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Aurionpro Solutions Ltd's share price today?

Aurionpro Solutions Ltd trades at ₹681, −43.2% over the past year. The company is valued at ₹3,762 Cr. The stock sits at the very bottom of its 52-week range (₹681–₹1,207), −23.3% versus its 200-day average. On the tape, the price is in a downtrend, 54 weeks in. — as of 11 September 2026.

What were Aurionpro Solutions Ltd's latest quarterly results?

Aurionpro Solutions Ltd reported revenue of ₹358 Cr and net profit of ₹45.0 Cr for the Jun 26 quarter. Revenue rose 6.2% and profit fell 11.8% year on year. Earnings per share were ₹8.30. The operating margin was 17.0%, 3.0 pp lower than a year earlier. — as of 11 September 2026.

What is Aurionpro Solutions Ltd's revenue?

Aurionpro Solutions Ltd reported revenue of ₹358 Cr in the Jun 26 quarter, +6.2% year on year. For the full FY26 fiscal year, revenue was ₹1,411 Cr (+20.3%). Over the last 10 years revenue compounded at 7.1% a year. — as of 11 September 2026.

What is Aurionpro Solutions Ltd's profit?

Aurionpro Solutions Ltd earned ₹45.0 Cr of net profit in the Jun 26 quarter, −11.8% year on year. Full-year FY26 profit was ₹212 Cr. The operating margin ran 17.0% in the latest quarter. — as of 11 September 2026.

What is Aurionpro Solutions Ltd's market cap?

Aurionpro Solutions Ltd's market capitalisation is ₹3,762 Cr at a share price of ₹681. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.

What is Aurionpro Solutions Ltd's P/E ratio?

Aurionpro Solutions Ltd trades at a P/E of 18.0×, at the 64th percentile of its own 11-year range, against a long-run median of 11.5×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.

Does Aurionpro Solutions Ltd pay a dividend?

Yes — Aurionpro Solutions Ltd's dividend payout was 10% of profit in FY26, and it recorded a payout in 10 of its last 13 reported fiscal years. One of those years shows a negative ratio because profit itself was negative. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.

Is Aurionpro Solutions Ltd overvalued?

On its own history, Aurionpro Solutions Ltd looks mid-range: its P/E of 18.0× sits at the 64th percentile of its 11-year range (long-run median 11.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.

Is Aurionpro Solutions Ltd growing?

Not right now — Aurionpro Solutions Ltd's latest numbers are shrinking: latest-quarter revenue +6.2% year on year, profit −11.8%, and the margin −3.0 pp at 17.0%. The 10-year compound rates are 7.1% (revenue) and 14.4% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.

How is Aurionpro Solutions Ltd performing?

Aurionpro Solutions Ltd is in a downtrend, 54 weeks in. Its latest quarter's revenue rose 6.2% and profit fell 11.8% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 11 September 2026.

What stage is Aurionpro Solutions Ltd in?

Topping out — revenue, profit and EPS growth have decelerated hard (revenue growth +35.4% at its peak → +14.8% latest) while ROCE still reads 15.5%. The read comes from the last 12 quarters of growth (revenue growth +14.8% latest, profit growth +5.1% latest, eps growth +5.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.

Is Aurionpro Solutions Ltd in an uptrend?

No — the price is in a downtrend (week 54 of stage 4), trading −23.3% versus its 200-day average and at the very bottom of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.

Is Aurionpro Solutions Ltd beating the market?

Not lately — on a trailing-13-week view Aurionpro Solutions Ltd is currently behind the NIFTY 500 (7 weeks and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +1,036% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.

Will Aurionpro Solutions Ltd's share price go up?

This page publishes no price forecast for Aurionpro Solutions Ltd. What it measures instead: the share price is ₹681, the price is in a downtrend 54 weeks in. Its P/E of 18.0× sits at the 64th percentile of its own 11-year range. — as of 11 September 2026.

Who owns Aurionpro Solutions Ltd?

Promoters hold 26.9% of Aurionpro Solutions Ltd, foreign institutions 16.0%, domestic institutions 1.5% and the public 55.6% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 3.2 points over 8 quarters. — as of 11 September 2026.

Does Aurionpro Solutions Ltd have too much debt?

No — Aurionpro Solutions Ltd's debt-to-equity is 0.04, and operating profit covers the interest bill 28×. FY26 borrowings were ₹61.0 Cr against equity of ₹1,738 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.

What is Aurionpro Solutions Ltd's capex?

Aurionpro Solutions Ltd spent ₹763 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹179 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.

What is Aurionpro Solutions Ltd's cash flow?

Aurionpro Solutions Ltd generated ₹56.0 Cr of operating cash flow in FY26 and ₹−123 Cr of free cash flow after ₹179 Cr of capital spending. Reported profit that year was ₹212 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 11 September 2026.

Is Aurionpro Solutions Ltd's profit real cash?

Mostly — over the last 3 fiscal years, 69% of Aurionpro Solutions Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹56.0 Cr against reported profit of ₹212 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.

Where is Aurionpro Solutions Ltd in its business cycle?

Aurionpro Solutions Ltd's FY26 operating margin was 20.0%, against a 13-year band of 9.0%–23.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 17.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.

What growth does Aurionpro Solutions Ltd's price assume?

At its price on 13 June 2026, Aurionpro Solutions Ltd was priced for profit growth of about 11.2% a year. Profit itself has compounded 14.4% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.

What could break the Aurionpro Solutions Ltd story?

The sharpest disagreement: annual EPS moved +12.3% against a −43.2% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.

Is Aurionpro Solutions Ltd a stock worth studying right now?

This is not investment advice. The machine read: Aurionpro Solutions Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-11. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI